.jpg)
.png)
Top Stories
On April 23, Amarin Corp. issued a press release announcing that the U.S. FDA has accepted its Supplemental New Drug Application (sNDA) seeking approval for the marketing and sale of Vascepa (icosapent ethyl) capsules for use as an adjunct to diet in the treatment of adult patients with high... more
Patient-centered recommendations for people needing additional cholesterol reduction Download the NLA PCSK9 Update Infographic PHILADELPHIA — The National Lipid Association (NLA) assembled a panel of experts to update its guidance for the use of PCSK9 antibody therapy made in the... more
James A. Underberg, MD, MS, Elected President during the 2017 NLA Scientific Sessions in Philadelphia PHILADELPHIA, Pa. — The National Lipid Association (NLA) announced the election of new President James A. Underberg, MD, MS, FACPM, FACP, FASPC, FNLA, on Saturday at the 2017 Scientific Sessions... more
Responses from healthcare workers show significant barriers to prescriptions PCSK9 Inhibitors Survey Findings Infographic Download PCSK9 Inhibitors Approval Checklist Download JACKSONVILLE, Fla. — The National Lipid Association (NLA) released on Wednesday the results of its survey on... more
The U.S. Food and Drug Administration released a Drug Safety Communication on July 20, 2021, concerning the removal of the strongest warning against using statins during pregnancy. The warning states that statins should never be used in any patients during pregnancy. After reviewing recent... more
Further results from the two phase 3 trials of the omega-3 fatty acid product ethyl eicosapentaenoic acid (EPA) (AMR101, Amarin), which showed the agent reduced triglycerides without increasing low-density lipoprotein (LDL) and reduced the number of atherogenic particles, were presented last week... more
Amit Khera, M.D., Saskia Neher, Ph.D., each earn two-year grant for lipid disorder research NLA Junior Faculty Research Award Information JACKSONVILLE, Fla. — The National Lipid Association (NLA) announced on Thursday the recipients of its inaugural Junior Faculty Research Awards for... more
Novartis announced that the U.S. Food and Drug Administration (FDA) approved Leqvio (inclisiran) as an adjunct to diet and maximally tolerated statin therapy for the treatment of adults with clinical atherosclerotic cardiovascular disease (ASCVD) or heterozygous familial hypercholesterolemia (HeFH... more
When Kennedi Thompson started developing xanthomas – fatty deposits that appear as white, raised bumps on the skin – her parents initially thought she was having an allergic reaction. Fox News - January 18, 2012
In >95% of patients, high triglycerides reflect the burden of the effects of more than 30 genes involved in triglyceride pathways Published in Lancet Diabetes & Endocrinology,1 Free to download from 31 January – 28 February 2014 at http://www.thelancet.com/journals/landia/article/... more